Page 117 - IJB-10-5
P. 117

International Journal of Bioprinting                                 3D bioprinting for organoid-derived EVs




            Table 5. Current research on organoids as promising models for studying extracellular vesicles in various inflammatory diseases.
             Disease model            Key findings                                                     Ref.
             Inflammatory bowel disease  EVs from human intestinal organoids modulated LPS-induced inflammatory response, with   138
                                      various microRNA contributing to these effects.
             Acute kidney injury      EVs from 3D cultured MSC exhibited yield increase compared to those from 2D culture and   139
                                      have superior anti-inflammatory effects, significantly reducing renal injury.
             Osteochondral defects    EVs derived from 3D cultured umbilical MSC positively affected chondrocyte proliferation,   140
                                      migration, and stability, conferring chondroprotective effects and promoting osteochondral
                                      regeneration activity.
             Parkinson’s disease      EVs from cerebral organoids reduced oxidative stress and apoptosis in astrocytes while   141
                                      promoting neuronal differentiation.
             Retinal development and disease  EVs derived from retinal organoids regulate the expression of genes related to development,   142
                                      functions, and disease in retinal progenitor cells.
             Abbreviations: EVs, extracellular vesicles; LPS, lipopolysaccharide; 3D, three-dimensional; 2D, two-dimensional; and MSC, mesenchymal stem cell.


            translation, as scalability and low yields hinder large-  tissue regeneration, and disease treatment. Improving
            scale therapeutic applications. 147                organoid models using 3D bioprinting technologies to
                                                               better represent the cellular and molecular environment
               The  application  of  3D  bioprinting  technologies   of human tissues is crucial to addressing the limitations
            has  shown  significant  advancements in  enhancing  the   of current models and enhancing the efficacy of OEVs in
            function and properties of OEVs, improving production   various applications.
            efficiency, and offering the potential for regenerative
            medicine and immune-mediated treatment of chronic     Research indicates that bioprinted EVs can
            diseases. By utilizing automated ECM plating processes,   significantly impact various medical fields by promoting
            3D bioprinting enhances the speed, accuracy, and   angiogenesis, osteogenesis, chondrogenesis, myogenesis,
            performance of matrices, leading to improved organoid   and carcinoprevention. The current review includes
            production efficiency. The structural integrity, controlled   a total of eight bioprinted EVs studies covering a
            release, and targeted applications provided by 3D   variety of medical applications (Table 6). The study
            bioprinting offer a promising approach to maximize   by Maiullari  et al. specifically focuses on the use of
            the therapeutic benefits of EVs, making them more   3D-bioprinted endothelial-derived EVs for promoting
            effective in precision medicine applications, especially   neovascularization,  demonstrating the potential  of
            in inflammation.                                   bioprinted EVs in enhancing vascularization and
                                                               tissue  regeneration.   Zhang  et al.  demonstrated  that
                                                                               148
               Overall, the integration of 3D bioprinting in   3D-printed  polylactic  acid (PLA)  scaffolds with  MSC-
            generating  tissue  structures,  organoids,  and  EVs  holds   derived exosomes possess immunoregulatory potential
            immense potential for personalized cancer treatment,   and promote osteogenic differentiation, showing potential

            Table 6. Current studies of 3D-bioprinted extracellular vesicles for various medical applications.

             Medical application      Key findings                                                      Ref.
             Neovascularization       3D-bioprinted endothelial-derived EVs promoted vascularization and tissue regeneration.  148
             Bone tissue regeneration  3D-printed PLA scaffolds with MSC-derived exosomes promoted osteogenic differentiation.  149
             Osteogenesis and angiogenesis  hADSCs-EVs promoted bone formation and angiogenesis in vitro and in vivo.  150
             Improved migration and   Bioceramic-induced macrophage-derived EVs enhanced migration, immune response,   151
             osteogenesis             osteogenesis, and angiogenesis.
             Anti-cancer efficacy     Exo-ssDNA-SA-FasL induced tumor cell apoptosis and modulated immune responses.  152
             Cartilage and bone regeneration  MSC-derived EVs in ECM/GelMA bioink induced cartilage and bone regeneration.  153
             Myogenesis               Bioprinted M2-EVs promoted myogenesis and myotube formation in vitro.  154
             Cancer biomarker capture  EVs antibody microarrays captured plasma tumor-specific EVs for early cancer detection.  155
             Abbreviations: 3D, three-dimensional; ECM, extracellular matrix; EVs, extracellular vesicles; GelMA, gelatin methacryloyl; hADSCs, human adipose-
             derived stem cells; MSC, mesenchymal stem cell; PLA, Polylactic acid; and M2, M2 type macrophage.

            Volume 10 Issue 5 (2024)                       109                                doi: 10.36922/ijb.4054
   112   113   114   115   116   117   118   119   120   121   122